Nazar Al Saidi, MD
Psychiatry · Owosso, MINPI 1831158153
Payments from drug & device makers
Across 1,244 payments — averaging $12.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Sunovion Pharmaceuticals Inc.$2K
- Teva Pharmaceuticals USA, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Neurocrine Biosciences, Inc.$1K
- plus $6K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 208 | $2,452 |
| Sunovion Pharmaceuticals Inc. | 278 | $1,896 |
| Teva Pharmaceuticals USA, Inc. | 116 | $1,486 |
| Otsuka America Pharmaceutical, Inc. | 95 | $1,442 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 103 | $1,343 |
| Neurocrine Biosciences, Inc. | 63 | $1,014 |
| Johnson & Johnson | 71 | $931 |
| Alkermes, Inc. | 43 | $926 |
| Lundbeck LLC | 60 | $922 |
| Supernus Pharmaceuticals, Inc. | 50 | $680 |
| Axsome Therapeutics, Inc. | 30 | $559 |
| Takeda Pharmaceuticals U.S.A., Inc. | 33 | $545 |
| Vanda Pharmaceuticals Inc. | 31 | $474 |
| E.r. Squibb & Sons, L.L.C. | 21 | $243 |
| Corium, LLC | 16 | $242 |
| Idorsia Pharmaceuticals US Inc | 6 | $109 |
| Validus Pharmaceuticals LLC | 4 | $79 |
| Collegium Pharmaceutical, Inc. | 3 | $64 |
| Avanir Pharmaceuticals, Inc. | 3 | $57 |
| Almatica Pharma LLC | 2 | $38 |
| Ironshore Pharmaceuticals Inc. | 1 | $24 |
| Vertical Pharmaceuticals, LLC | 1 | $19 |
| Neuronetics, Inc. | 1 | $16 |
| Livanova USA, Inc. | 1 | $15 |
| OWP Pharmaceuticals, Inc. | 1 | $14 |
| Shire North American Group Inc | 1 | $14 |
| Jazz Pharmaceuticals Inc. | 1 | $12 |
| Brainsway USA Inc | 1 | $12 |
How this compares
$15,627 in reported general payments places this provider in the 95th percentile of 1,166 psychiatry providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Owosso
- Andreas SidiropoulasDetroit$2.8M
- Joel YoungRochester Hills$1.9M
- Welton WashingtonYpsilanti$1.4M
- Rajaprabhakaran RajarethinamAnn Arbor$1.2M
- Eric AchtyesGrand Rapids$705K
- Manzar RajputMonroe$612K
- William GuySouthfield$562K
- Brian MickeyAnn Arbor$490K
- Sagar ParikhAnn Arbor$331K
- Robert LagrouClarkston$267K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.